Head-to-head comparison of fibroblast activation protein inhibitors (FAPI) radiopharmaceuticals and [18F]FDG in gynaecological malignancies: systematic literature review and meta-analysis
Head-to-head comparison of fibroblast activation protein inhibitors (FAPI) radiopharmaceuticals and [18F]FDG in gynaecological malignancies: systematic literature review and meta-analysis
Salvatore Annunziata, Lejla Alić, María Ruggiero, Giovanni Scambia et al.
Citations
5 citations
Journal
European Journal of Nuclear Medicine and Molecular Imaging
Topics
Peptidase Inhibition and Analysis
Field-Weighted Citation Impact (FWCI)
5.23
article
Head-to-head comparison of fibroblast activation protein inhibitors (FAPI) radiopharmaceuticals and [18F]FDG in gynaecological malignancies: systematic literature review and meta-analysis
Salvatore Annunziata, Lejla Alić, María Ruggiero, Giovanni Scambia, Evis Sala, Irina Primac, Lioe‐Fee de Geus‐Oei, Vittoria Rufini, Elizabeth J. de Koster, Angela Collarino, Cristina Mueller, Anita Florit, Wolfgang P. Fendler, Giusi Pisano, Anna Fagotti, Floris H. P. van Velden, Serena Sassano
article en
5 citations
Abstract
No abstract available for this paper.
Publication Tag
European Journal of Nuclear Medicine and Molecular ImagingVol. 52(11)
Institutions
Università Cattolica del Sacro Cuore (IT), Leiden University Medical Center (NL), Paul Scherrer Institute (CH), Agostino Gemelli University Polyclinic (IT), ETH Zurich (CH), Medisch Centrum Haaglanden (NL), Belgian Nuclear Research Centre (BE), Essen University Hospital (DE), University of Twente (NL), Delft University of Technology (NL)
Funders
Innovative Health Initiative, Università Cattolica del Sacro Cuore